198 related articles for article (PubMed ID: 12769749)
1. Anti-cytokines and cytokines in the treatment of rheumatoid arthritis.
Taylor PC
Curr Pharm Des; 2003; 9(14):1095-106. PubMed ID: 12769749
[TBL] [Abstract][Full Text] [Related]
2. Anti-cytokine therapy for rheumatoid arthritis.
Maini RN; Taylor PC
Annu Rev Med; 2000; 51():207-29. PubMed ID: 10774461
[TBL] [Abstract][Full Text] [Related]
3. [Present importance of direct immunologically based intervention strategies using anticytokines in rheumatoid arthritis].
Boehme MW; Gao IK
Z Rheumatol; 1999 Oct; 58(5):251-66. PubMed ID: 10591973
[TBL] [Abstract][Full Text] [Related]
4. Embracing novel cytokines in RA - complexity grows as does opportunity!
Hueber AJ; Asquith DL; McInnes IB; Miller AM
Best Pract Res Clin Rheumatol; 2010 Aug; 24(4):479-87. PubMed ID: 20732646
[TBL] [Abstract][Full Text] [Related]
5. Cytokine inhibitors in the treatment of rheumatoid arthritis.
Gabay C
Expert Opin Biol Ther; 2002 Feb; 2(2):135-49. PubMed ID: 11849114
[TBL] [Abstract][Full Text] [Related]
6. [New drugs and treatment strategies for rheumatoid arthritis].
Fantini F
Recenti Prog Med; 2003 Sep; 94(9):361-79. PubMed ID: 12942798
[TBL] [Abstract][Full Text] [Related]
7. Cytokines as therapeutic targets in rheumatoid arthritis and other inflammatory diseases.
Siebert S; Tsoukas A; Robertson J; McInnes I
Pharmacol Rev; 2015; 67(2):280-309. PubMed ID: 25697599
[TBL] [Abstract][Full Text] [Related]
8. Biological response modifiers in the management of rheumatoid arthritis.
Louie SG; Park B; Yoon H
Am J Health Syst Pharm; 2003 Feb; 60(4):346-55. PubMed ID: 12625216
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of rheumatoid arthritis is associated with a reduction in synovial membrane cytokines and cell adhesion molecule expression.
Smith MD; Slavotinek J; Au V; Weedon H; Parker A; Coleman M; Roberts-Thomson PJ; Ahern MJ
Rheumatology (Oxford); 2001 Sep; 40(9):965-77. PubMed ID: 11561106
[TBL] [Abstract][Full Text] [Related]
10. Combined inhibition of tumor necrosis factor α and interleukin-17 as a therapeutic opportunity in rheumatoid arthritis: development and characterization of a novel bispecific antibody.
Fischer JA; Hueber AJ; Wilson S; Galm M; Baum W; Kitson C; Auer J; Lorenz SH; Moelleken J; Bader M; Tissot AC; Tan SL; Seeber S; Schett G
Arthritis Rheumatol; 2015 Jan; 67(1):51-62. PubMed ID: 25303306
[TBL] [Abstract][Full Text] [Related]
11. Modern treatment strategies in rheumatoid arthritis.
Hetland ML
Dan Med Bull; 2011 Nov; 58(11):B4320. PubMed ID: 22047935
[TBL] [Abstract][Full Text] [Related]
12. The rationale for the current boom in anti-TNFalpha treatment. Is there an effective means to define therapeutic targets for drugs that provide all the benefits of anti-TNFalpha and minimise hazards?
Feldmann M; Bondeson J; Brennan FM; Foxwell BM; Maini RN
Ann Rheum Dis; 1999 Nov; 58 Suppl 1(Suppl 1):I27-31. PubMed ID: 10577970
[TBL] [Abstract][Full Text] [Related]
13. Rheumatoid arthritis: Recent advances on its etiology, role of cytokines and pharmacotherapy.
Alam J; Jantan I; Bukhari SNA
Biomed Pharmacother; 2017 Aug; 92():615-633. PubMed ID: 28582758
[TBL] [Abstract][Full Text] [Related]
14. [Proposal for anti-TNFalpha therapy in adult patients with rheumatoid arthritis].
Curković B; Babić-Naglić D; Morović-Vergles J; Anić B; Grazio S
Reumatizam; 2007; 54(1):16-9. PubMed ID: 18450272
[TBL] [Abstract][Full Text] [Related]
15. Characterization of pristane-induced arthritis, a murine model of chronic disease: response to antirheumatic agents, expression of joint cytokines, and immunopathology.
Patten C; Bush K; Rioja I; Morgan R; Wooley P; Trill J; Life P
Arthritis Rheum; 2004 Oct; 50(10):3334-45. PubMed ID: 15476226
[TBL] [Abstract][Full Text] [Related]
16. The use of anakinra, an interleukin-1 receptor antagonist, in the treatment of rheumatoid arthritis.
Cohen SB
Rheum Dis Clin North Am; 2004 May; 30(2):365-80, vii. PubMed ID: 15172046
[TBL] [Abstract][Full Text] [Related]
17. IL-1 inhibitors: novel agents in the treatment of rheumatoid arthritis.
Gabay C
Expert Opin Investig Drugs; 2000 Jan; 9(1):113-27. PubMed ID: 11060665
[TBL] [Abstract][Full Text] [Related]
18. Cytokine-modulating strategies and newer cytokine targets for arthritis therapy.
Venkatesha SH; Dudics S; Acharya B; Moudgil KD
Int J Mol Sci; 2014 Dec; 16(1):887-906. PubMed ID: 25561237
[TBL] [Abstract][Full Text] [Related]
19. Clinical trial outcome of anti-tumour necrosis factor alpha therapy in rheumatic arthritis.
Choy E
Cytokine; 2004 Nov 21-Dec 7; 28(4-5):158-61. PubMed ID: 15588689
[TBL] [Abstract][Full Text] [Related]
20. Evidence that cytokines play a role in rheumatoid arthritis.
Brennan FM; McInnes IB
J Clin Invest; 2008 Nov; 118(11):3537-45. PubMed ID: 18982160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
